24 October 2018 – Chembio, a leading point-of-care diagnostics company focused on infectious diseases, and the shareholders of opTricon GmbH, a privately-held developer and manufacturer of hand-held analyzers for rapid diagnostic tests, signed a definitive agreement to acquire all shares in opTricon GmbH in an all-cash deal for 5.5 million USD. The transaction is expected to […]
For What Truly Counts
